Role of previous hospitalization in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control study

Cecilia M J Drapeau, Claudio Angeletti, Anna Festa, Nicola Petrosillo, Cecilia M J Drapeau, Claudio Angeletti, Anna Festa, Nicola Petrosillo

Abstract

Background: HIV-infected subjects have high incidence rates of Staphylococcus aureus infections, with both methicillin-susceptible and methicillin-resistant (MRSA) strains. Possible explanations could include the high burden of colonization, the behavioral risk factors, and the frequent exposures to health care facilities of HIV-infected patients. The purpose of the study was to assess the risk factors for clinically- significant methicillin-resistant Staphylococcus aureus (CS-MRSA) infections in HIV-infected patients admitted to Infectious Diseases Units.

Methods: From January 1, 2002 to December 31, 2005, we conducted a retrospective case-control (1:2) study. We identified all the cases of CS-MRSA infections in HIV-infected patients admitted to the National Institute for Infectious Diseases (INMI) "Lazzaro Spallanzani" in the 4-year study period. A conditional logistic regression model was used to identify risk factors for CS-MRSA infection.

Results: We found 27 CS-MRSA infections, i.e. 0.9 CS-MRSA infections per 100 HIV-infected individuals cared for in our Institute. At multivariate analysis, independent predictors of CS-MRSA infection were cumulative hospital stay, invasive procedures in the previous year, and low CD4 cell count. Particularly, the risk for CS-MRSA increased by 14% per an increase of 5 days hospitalization in the previous year. Finally, we identified a low frequency of community-acquired MRSA infections (only 1 of 27; 3.7%) among HIV-infected patients.

Conclusion: Clinicians should be aware of the risk for CS-MRSA infection in the clinical management of HIV-infected patients, especially in those patients with a low CD4 cell count, longer previous hospital stay, and previous invasive procedures.

Figures

Figure 1
Figure 1
Odds Ratios of MRSA infection according to cumulative hospital stay in the previous year. Trend of Odd Ratios of MRSA infection adjusted for age (≤ 42 years and > 42 years) according to total number of hospital days in the previous year.

References

    1. European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2004
    1. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–9. doi: 10.1086/345476.
    1. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med. 1989;320:1188–96.
    1. Lowy FD. Staphylococcus aureus Infections. N Engl J Med. 1998;339:520–532. doi: 10.1056/NEJM199808203390806.
    1. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41:269–72. doi: 10.1086/430788.
    1. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am J Med. 1987;82:900–6. doi: 10.1016/0002-9343(87)90150-1.
    1. Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis. 2001;33:1412–6. doi: 10.1086/322656.
    1. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicaemia in patients with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1992;11:985–989. doi: 10.1007/BF01967787.
    1. Tumbarello M, de Gaetano Donati K, Tacconelli E, Fadda G, Cauda R. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother. 2002;50:375–382. doi: 10.1093/jac/dkf126.
    1. Jacobson MA, Gellermann H, Chambers H. S. aureus bacteremia and recurrent staphylococcal infection in patients with AIDS and AIDS-related complex. Am J Med. 1998;85:172–176.
    1. Hidron AI, Kourbatova EV, Halvosa JS, Terrel BJ, McDougal LK, Tenover FC, Blumberg HM, King MD. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 2005;41:159–66. doi: 10.1086/430910.
    1. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus : epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505–20.
    1. Padoveze MC, Tresoldi AT, von Nowakonski A, Aoki FH, Branchini ML. Nasal MRSA colonization of AIDS patients cared for in a Brazilian university hospital. Infect Control Hosp Epidemiol. 2001;22:783–5. doi: 10.1086/501864.
    1. McDonald LC, Lauderdale TL, Lo HJ, Tsai JJ, Hung CC. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS. 2003;14:473–7. doi: 10.1258/095646203322025786.
    1. Mathews WC, Caperna JC, Barber RE, McCutchan JA. Incidence of and risk factors for clinically Significant Methicillin-Resistant Staphylococcus aureus Infection in a Cohort of HIV-infected adults. J Acquir Immune Defic Syndr. 2005;40:155–60. doi: 10.1097/01.qai.0000179464.40948.b9.
    1. Onorato M, Borucki MJ, Baillargeon G, Paar DP, Freeman DH, Cole CP, Mayhall CG. Risk factors for colonization or infection due to methicillin-resistant Staphylococcus aureus in HIV-positive patients: a retrospective case-control study. Infect Control Hosp Epidemiol. 1999;20:26–30. doi: 10.1086/501556.
    1. Minnesota Department of Health (MDH). Infectious Diseases Epidemiology, Prevalence and Control Division. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
    1. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM. Emergence of Community-Associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health-care-associated blood stream infections. Clin Infect Dis. 2006;42:647–656. doi: 10.1086/499815.
    1. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R. Comparison of community-and health-care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976–84. doi: 10.1001/jama.290.22.2976.
    1. Monaco M, Antonucci R, Palange P, Venditti M, Pantosti A. Methicillin-resistant Staphylococcus aureus necrotizing pneumonia. Emerg Infect Dis. 2005;11:1647–1648.
    1. Pistella E, Campanile F, Bongiorno D, Stefani S, Di Nucci GD, Serra P, Venditti M. Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus endocarditis unresponsive to vancomycin therapy with Linezolid. Scand J Infect Dis. 2004;36:222–5. doi: 10.1080/00365540410019345.
    1. Smith NP, Nelson MR, Azadian B, Gazzard BG. An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-seropositive persons. Int J STD AIDS. 1998;9:726–730. doi: 10.1258/0956462981921468.
    1. Villician JS, Barkham T, Earnest A, Paton NI. Prevalence of and risk factors for nasal colonization with Staphylococcus aureus among Human Immunodeficiency virus-positive outpatients in Singapore. Infect Control Hosp Epidemiol. 2004;25:438–440. doi: 10.1086/502420.
    1. Harbarth S, Sax H, Frankhauser-Rodriguez C, Schrenzel J, Agostinho A, Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med. 2006;119:e15–23. doi: 10.1016/j.amjmed.2005.04.042.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅